Starting CML Treatment: Collaborative Choices for Better Outcomes

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

• What are some of the most important considerations when starting treatment for a newly diagnosed patient with CML? How do age, comorbidities, and other considerations factor into the treatment plan?
  • Describe your best practices in helping newly diagnosed patients with CML better understand their treatment plan given the complexities involved.
• In your experience, what strategies promote transparent communication around treatment considerations?
  • How can patients feel empowered to collaborate with their healthcare team to make an informed decision on the optimal initial treatment?